Serum ox-LDL Level and Severity of Stenosis in Coronary Arteries
Abstract
No Abstract
Mahmoudi MJ, Mahmoudi M, Siassi F, Shokri F, Eshraghian MR, Zarnani AH, Chahardoli R, Hedayat M,Khoshnoodi J, Nayeri H, Rezaei N, Saboor-Yaraghi AA. Lymphocyte cytotoxicity of oxLDL in patients with atherosclerosis. Iran J Immunol 2011;8(1): 27-33.
Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002; 1585:213-21.
Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20:707-27.
Najafi M, Alipoor B. Serum ox-LDL level is reduced with the extent of stenosis in coronary arteries. Acta Medica Iranica 2013;51(5):314-319.
Kougialis S, Skopelitis E, Gialernios T, Nikolaou S, Kroustalis A, Katsadorou E, Gialernios K, Zervou A, Gika E, Polydorou A, Polydorou V, Drakoulis C, Iliopoulos N, Dermitzakis I, Mpilinis H, Polydorou A. Atorvastatin therapy is associated with improvement of oxidized lowdensity lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty. Int Angiol 2010;29(4):338-47.
Huang H, Ma R, Liu D, Liu C, Ma Y, Mai W, Dong Y. Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease. Dis Markers 2012;33(6):295-302.
| Files | ||
| Issue | Vol 51, No 7 (2013) | |
| Section | Original Article(s) | |
| Keywords | ||
| No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
